CMEinfo Comprehensive Review of Urology 2018

Comprehensive Review of Urology Provided by: Oakstone Publishing, LLC _____________________________________________________________________________________________________________________________________ 310 DATE OF ORIGINAL RELEASE: November 1, 2018 DATE CREDITS EXPIRE: November 1, 2021 TARGET AUDIENCE: The activity was designed to provide urologists, urology fellows and residents, surgery residents interested in urology, other licensed individual practitioners or ancillary staff interested in urology, or who participate in the delivery of urologic care with current, relevant, and condensed information needed to pass certification and recertification exams. ESTIMATED TIME TO COMPLETE: It is estimated that it should take the average learner 56 hours to complete the activity. ACCREDITATION: Oakstone Publishing, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Oakstone Publishing, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. DESIGNATION: Oakstone Publishing, LLC designates this enduring material for a maximum of 56 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Contact Hours: 56 SPECIAL PREREQUISITES FOR PARTICIPANTS: There are no prerequisites for participants. METHOD OF PARTICIPATION: Review Video/Audio program, score 70% or greater on the required posttest to assess the knowledge gained from reviewing the program and complete the comprehensive activity evaluation. LEARNING OBJECTIVES: At the conclusion of this activity, the participant will be able to:  Discuss the discrete urologic infections and inflammatory disorders and how they are best managed.  Describe the best surgical approaches for urologic trauma.  Identify the ideal treatment approaches for patients with kidney cancer.  Differentiate between non-muscle invasive bladder cancer and muscle invasive bladder cancer.  Summarize the most efficacious therapies for bladder cancer.  Differentiate between medical approaches and surgical approaches for prostate cancer.  Describe active surveillance in prostate cancer.  Assess the importance of adolescent and transitional urology.  List common and uncommon urologic conditions in children.  Define male and female sexual dysfunction.  Explain evaluation and medical and behavioral management of urinary incontinence in women.  Distinguish among the benefits of medical and surgical management of lithiasis. FACULTY AFFILIATIONS DISCLOSURE: Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors, and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing’s planners, content reviewers, and editorial staff disclose no relevant commercial interests. Disclosure information for all individuals in control of the content of the activity is located on the disclosure slides in the PDF and printed syllabus. WARNING: The copyright proprietor has licensed the picture contained on this recording for private home use only and prohibits any other use, copying, reproduction, or performance in public, in whole or in part (Title 17 USC Section 501 506). CMEinfo is not responsible in any way for the accuracy, medical or legal content of this recording. You should be aware that substantive developments in the medical field covered by this recording may have occurred since the date of original release. © 2018 Ebix, Inc. DBA Oakstone Publishing. LLC. CMEinfo is a registered trademark of Oakstone Publishing, LLC.